Can omeprazole cause hair loss? This is a question raised by many people taking this widely prescribed proton pump inhibitor (PPI) in the UK. Omeprazole is commonly used to treat gastro-oesophageal reflux disease (GORD), peptic ulcers, and dyspepsia, and whilst it is generally well tolerated, alopecia is listed as a rare side effect in its official Summary of Product Characteristics. Understanding the evidence, potential mechanisms, and what steps to take if you notice increased hair shedding can help you make informed decisions about your treatment in discussion with your GP or pharmacist.

Does Omeprazole Cause Hair Loss?

Alopecia is listed as a rare side effect of omeprazole in its official MHRA-approved Summary of Product Characteristics, estimated to affect fewer than 1 in 1,000 users, typically presenting as diffuse telogen effluvium.

Experiencing these side effects? Our pharmacists can help you navigate them →

Omeprazole is a proton pump inhibitor (PPI) widely prescribed across the UK for conditions such as gastro-oesophageal reflux disease (GORD), peptic ulcers, and dyspepsia. It works by irreversibly blocking the hydrogen-potassium ATPase enzyme system in the stomach's parietal cells, thereby reducing the production of gastric acid.^[1]

Hair loss — medically termed alopecia — is listed as a rare side effect of omeprazole in its official Summary of Product Characteristics (SmPC), as published on the MHRA/Electronic Medicines Compendium (EMC). 'Rare' in this context means it is estimated to affect fewer than 1 in 1,000 users. The BNF also lists alopecia as a rare adverse effect within the PPI drug class.

When PPIs do cause hair shedding, it typically presents as diffuse telogen effluvium — a condition in which hair follicles prematurely enter the resting (telogen) phase of the growth cycle, leading to increased shedding across the scalp rather than patchy loss. It is important to note that this pattern reflects the general presentation of drug-induced hair loss; there is limited omeprazole-specific evidence directly establishing this mechanism, and no definitive causal pathway has been fully characterised in the scientific literature.

Many individuals taking omeprazole never experience any hair-related changes, and for the vast majority, the medicine is well tolerated. If you have noticed increased hair shedding since starting omeprazole, it is worth discussing this with your GP or pharmacist, but you should not stop taking the medication without professional advice, as doing so could allow your underlying condition to worsen.

What the Evidence Says About PPIs and Hair Thinning

Evidence linking PPIs to hair loss is limited, but pharmacovigilance databases have recorded cases; the most plausible mechanism is indirect, via impaired absorption of vitamin B12, magnesium, or iron.

Not sure if this is normal? Chat with one of our pharmacists →

The evidence linking PPIs as a drug class — including omeprazole, lansoprazole, pantoprazole, and esomeprazole — to hair loss is limited but not entirely absent. A number of case reports and pharmacovigilance databases, including the European Medicines Agency's (EMA) EudraVigilance system and the MHRA's Yellow Card database, have recorded instances of alopecia in patients taking PPIs. However, case reports represent the lowest tier of clinical evidence and cannot confirm causation.

One proposed indirect mechanism relates to the effect of long-term PPI use on nutrient absorption. The strength of evidence varies by nutrient:

• Vitamin B12 — the association between long-term PPI use and reduced B12 absorption is well established; B12 is essential for healthy hair follicle cell turnover, and deficiency is a recognised cause of diffuse hair loss

• Magnesium — the MHRA has issued a Drug Safety Update specifically warning that long-term PPI use can cause hypomagnesaemia (low magnesium), which may indirectly affect hair growth cycles

• Iron — iron-deficiency anaemia is a well-recognised cause of diffuse hair loss, but the evidence that PPIs directly impair iron absorption is less consistent than for B12 and magnesium

• Zinc — zinc plays a role in hair tissue growth and repair, but the evidence linking PPI use to clinically significant zinc depletion is limited

NICE Clinical Knowledge Summaries (CKS) for GORD and dyspepsia recommend that long-term PPI therapy (generally beyond eight weeks) is reviewed periodically to confirm ongoing need and to ensure the lowest effective dose is used; nutritional risks are one consideration within this broader review. If omeprazole is contributing to hair thinning, it is more likely through an indirect nutritional pathway than through a direct toxic effect on hair follicles.

Blood tests to assess nutritional status can help clarify whether deficiency is a contributing factor. Routine testing of zinc or magnesium is not generally indicated unless clinically suspected; your GP will typically prioritise a full blood count (FBC), ferritin, vitamin B12, folate, and thyroid function tests based on your presentation. Your GP can arrange these as part of a routine review.

Other Medications and Conditions That Can Cause Hair Loss

Many medications and medical conditions — including thyroid disorders, iron-deficiency anaemia, and drugs such as warfarin or sodium valproate — can cause hair loss, so omeprazole should not be assumed to be the sole cause without thorough assessment.

Before attributing hair loss solely to omeprazole, it is essential to consider the broader clinical picture. Hair loss is a common complaint with a wide range of potential causes, and in many cases, multiple factors may be acting simultaneously.

Other medications known to cause hair loss include (this list is not exhaustive):

• Anticoagulants (e.g., warfarin, heparin)

• Antithyroid drugs (e.g., carbimazole)

• Certain antidepressants, mood stabilisers, and antiepileptics (e.g., lithium, sodium valproate)

• Retinoids (e.g., isotretinoin)

• Chemotherapy agents

• Beta-blockers (e.g., propranolol)

• Hormonal contraceptives in some individuals

• Interferons and some immunomodulatory therapies

Medical conditions that commonly cause hair thinning include:

• Hypothyroidism or hyperthyroidism

• Iron-deficiency anaemia

• Polycystic ovary syndrome (PCOS)

• Alopecia areata (an autoimmune condition)

• Androgenetic alopecia (male or female pattern baldness)

• Significant physical or emotional stress

• Nutritional deficiencies, including protein deficiency

• Coeliac disease and other malabsorption conditions

• Chronic systemic illness (e.g., chronic kidney disease, liver disease, systemic lupus erythematosus)

• Scalp infections such as tinea capitis (ringworm of the scalp), which may present with broken hairs, scaling, or erythema

• Scarring alopecias (e.g., lichen planopilaris), which can cause permanent hair loss if not treated promptly

Telogen effluvium — the most likely form of hair loss associated with PPI use — can also be triggered by illness, surgery, rapid weight loss, or hormonal changes such as those following childbirth. This means that even if a patient notices hair loss while taking omeprazole, the medication may not be the primary cause.

If you notice scaling, redness, pain, pustules, or broken hairs on the scalp, seek prompt GP assessment, as these features may suggest an inflammatory or infective cause requiring urgent evaluation. Suspected scarring alopecia in particular warrants prompt referral to a dermatologist, as delay can result in permanent hair loss. A thorough assessment by a GP, including a detailed medication history and relevant blood tests, is the most reliable way to identify the underlying cause and guide appropriate management.

When to Speak to Your GP or Pharmacist

Consult your GP promptly if hair loss is sudden, severe, patchy, or accompanied by scalp inflammation, systemic symptoms, or if you have been on omeprazole long-term without a recent medication review.

Most people who experience mild hair shedding while taking omeprazole do not need to seek urgent medical attention. However, there are certain circumstances in which it is important to consult a healthcare professional promptly.

You should speak to your GP or pharmacist if:

• Hair loss is sudden, severe, or rapidly progressive

• You notice patchy bald areas rather than diffuse thinning

• There are signs of scalp inflammation or infection — such as redness, scaling, pain, pustules, or broken hairs — which may indicate a condition requiring urgent assessment

• Hair loss is accompanied by other symptoms such as fatigue, weight changes, or skin changes (which may suggest a thyroid or autoimmune condition)

• You have been taking omeprazole long-term (more than 8–12 weeks) without a recent medication review

• You are concerned that a nutritional deficiency may be contributing

• Hair loss is causing significant psychological distress

If scarring alopecia or a fungal scalp infection (tinea capitis) is suspected, your GP may refer you promptly to a dermatologist, as early treatment is important to prevent permanent hair loss.

Your GP can arrange blood tests to check thyroid function, full blood count, ferritin (iron stores), vitamin B12, folate, and other relevant markers. If a nutritional deficiency is identified, supplementation may be recommended. In some cases, your GP may consider a supervised step-down in PPI dose or a switch to an alternative acid-suppressing medicine, such as the H2 receptor antagonist famotidine (currently available in the UK), in line with NICE CKS guidance and Specialist Pharmacy Service (SPS) advice on reviewing long-term PPI therapy.

It is strongly advised not to stop omeprazole abruptly without medical guidance. Sudden discontinuation can cause rebound acid hypersecretion, which may temporarily worsen reflux symptoms. Your GP or pharmacist can help you weigh the benefits and risks and make an informed decision about your treatment.

Managing Hair Loss While Taking Omeprazole

Management includes correcting identified nutritional deficiencies, reviewing PPI dose in line with NICE CKS guidance, and allowing up to 6–12 months for regrowth once the underlying trigger is addressed.

If you and your GP agree that omeprazole is a likely contributing factor to your hair loss, there are several practical steps that can be taken to manage the situation without necessarily discontinuing treatment.

Nutritional support is often the first consideration. If blood tests reveal deficiencies in iron, vitamin B12, or other micronutrients, your GP may recommend dietary changes or supplementation. Eating a balanced diet rich in protein, leafy green vegetables, nuts, seeds, and lean meats can support healthy hair growth. Supplements should only be taken on the basis of confirmed deficiency, as excessive intake of certain vitamins and minerals can itself cause harm.

Medication review is another important step. NICE CKS guidance on GORD and dyspepsia recommends that patients on long-term PPIs are reviewed at least annually to confirm that the lowest effective dose is being used. SPS guidance on deprescribing also supports a step-down approach where clinically appropriate. In some cases, using the medication at a lower dose or on an as-needed basis (rather than continuously) may reduce the risk of nutritional side effects while still managing symptoms effectively.

Recovery expectations: In most cases of drug-related telogen effluvium, shedding begins to settle within a few months once the underlying trigger is addressed. Fuller regrowth may take up to 6–12 months. Understanding this timeline can help manage expectations and reduce anxiety during the recovery period.

From a hair care perspective, gentle handling of hair — avoiding excessive heat styling, tight hairstyles, and harsh chemical treatments — can help minimise further breakage during a period of increased shedding. Topical minoxidil is licensed in the UK for androgenetic alopecia (as confirmed in the BNF); its use in drug-induced telogen effluvium is off-label, and any decision to use it should be discussed with a healthcare professional. In most cases of drug-related hair loss, shedding improves once the underlying cause is addressed.

Reporting Side Effects Through the MHRA Yellow Card Scheme

Patients and healthcare professionals can report suspected omeprazole side effects, including hair loss, directly to the MHRA via the Yellow Card website or app — a suspicion alone is sufficient to submit a report.

In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) operates the Yellow Card scheme, which is the national system for collecting reports of suspected adverse drug reactions (ADRs). The scheme plays a vital role in post-marketing surveillance, helping regulators identify safety signals that may not have been apparent during clinical trials.

If you believe that omeprazole or any other medicine has caused or contributed to hair loss, you are encouraged to submit a Yellow Card report. Reports can be made by:

• Patients and members of the public directly via the MHRA Yellow Card website (yellowcard.mhra.gov.uk) or the Yellow Card app

• Healthcare professionals, including GPs, pharmacists, and nurses

• Carers on behalf of a patient

You do not need to be certain that the medicine caused the side effect — a suspicion is sufficient to make a report. The information you provide contributes to a broader dataset that helps the MHRA monitor the safety profile of medicines in real-world use. This is particularly valuable for rare side effects such as hair loss, which may be under-reported in clinical trial populations.

Reporting a suspected side effect does not mean the medicine will be withdrawn or that you will be contacted to change your treatment. It is simply a way of contributing to ongoing medicine safety monitoring. Your GP or pharmacist can assist you in completing a Yellow Card report if needed, and the process typically takes only a few minutes. Proactive reporting by patients and clinicians alike helps ensure that prescribing information remains accurate and up to date for everyone.

Frequently Asked Questions